Aesica Pharmaceuticals Limited
Overview
Aesica Pharmaceuticals Limited is a leading contract development and manufacturing organization (CDMO) that provides extensive pharmaceutical services ranging from drug development to finished product manufacturing. It is a subsidiary of Recipharm AB, a global CDMO headquartered in Sweden.
Core services & business areas
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Aesica Pharmaceuticals Limited is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Aesica Pharmaceuticals Limited holds 0 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- PAROXETINE HYDROCHLORIDE HEMIHYDRATEInactive2011-05-05
- PAROXETINE HYDROCHLORIDEInactive2000-06-01
FDA compliance signals
2 FDA enforcement records linked to this company.
- 4832014-06-20
Absence of Written Procedures
- 4832014-06-20
Investigations of discrepancies, failures
Is this Aesica Pharmaceuticals Limited? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.